Wednesday, September 2, 2026 · Bullpen.News

Skip to this day’s stories

Bullpen.News From Edwin Dorsey

Get Daily Recap Feedback

A Busted Businesses or a Cyclical Bottom?

Two U.S. protein-snacking companies lost $6 billion in market value as impairments, inventory growth and margin pressure test whether the category has reached a cyclical bottom.

SMPL $852MBRBR $920M

The Value Road Sep 2 12 clicks

Sep 2 SGMO $60M

Sangamo Bankruptcy (SGMOQ)

Triple S Special Situations Investing 6 clicks

Sep 2 ATMTF $195M

An ATM that starts to spit out cash

The Oak Bloke 7 clicks

From X

@natstewart5 Sep 2

Nat Stewart on X

$GSM Ferroglobe up today on announcement of a European review of antidumping measures on Chinese silicon metal Has been in a volatile trading range for years, but potential bull points appear be stacking up. (I own long dated calls, watchlist stock)

@natstewart5 Sep 2 1 click

Nat Stewart on X

$TLYS turnaround looking good: ° Same-store comps +12.1% ° August (first month of Q3) comps +14.6% ° 13 month steak of growth ° Cash + securities $62.2M vs $50.7M ° Q2 net income $8.4M up from $3.2M Gross margin +300 bps Most important, earings I bought my daughter on Tilly's store visit are her fav pair, so wins all around 🥳

@BlueDuckCap Sep 2

BDC on X

The rheumatologists on the call also confirmed 2 things: 1.) XGN tests are superior in identifying lupus markers vs legacy and 2.) Myositis is critical to rule out early to avoid very serious lung issues. $XGN launches Myositis labs early next year. Confirmed the entire bull case imho.

@natstewart5 Sep 2

Nat Stewart on X

@HiddenGemsInves $CHCI ° Asset light, high ROIC asset manager ° Track record of revenue, FCF growth, clear strategy ° ~30% owned by Dwight Shar, founder/former CEO of $NVR ° move into data center development is a potential grand slam - a cheap call option

@SowingAlphaSeed Sep 2

Farmer on X

@simcity31 $ORR has been a great investment and I'm happy with it. I just don't think any investment should be sized as large as I sized it. https://t.co/HnwLbpAPID

@SowingAlphaSeed Sep 2

Farmer on X

@GrumpierBTDay @vanillager Off topic, but have you looked at $AERG?

@stockgutter Sep 2

SG on X

I think the starman parent owns incipio (phone cases) and incase (backpacks, computer cases and electronics cases). A better fit would be buying targus off $RILY but my best guess is that they are after GoPro for patents they intend to use to become a troll. No proof just what makes sense here.

@majgeoinvesting Sep 2

Maj Soueidan on X

@RodrigoLezama7 @ALDeAng08 @Mike10947310 @MicrocapDr Yeah, liquidity excuse is bogus. Being right fixes everything. Big caps have fallen 50% in one day on earnings misses. Remember when illiquid $MUEL was $45 with a P/E of 4x in 2024. Pessimists said it wouldn’t get much higher. P/E got as high as 15x as the stock went to $500.

Tectonic Therapeutic: Competitor Data Strengthens The TX45 Bull Case

Tectonic Therapeutic's TX45 CpcPH-HFpEF program gains support from Merck's CADENCE data; Phase 1b hemodynamics and cash through Q1 2029 set…

Equity Eagle Sep 2 2 clicks

EVC Update

EVC reported a solid second quarter and outlook.

Nat Stewart - Stock Picking Newsletter Sep 1 15 clicks

$LMB: Limbach missed the data center boom. Is that the opportunity? | 1 Main Capital

Limbach's EBITDA fell 30% as organic revenue declined, but 1 Main Capital calls the weakness temporary and views CYMCOR as its first…

Yet Another Value Podcast Sep 1 9 clicks

GoPro sold itself at 9:20 AM to get ahead of a meme stock

GoPro rushed out its Starman Optical merger after Markiplier-driven buying sent GPRO up roughly 90% premarket, offering shareholders $1.14…

Yet Another Value Blog Sep 1 4 clicks

Shattuck Labs: A Receptor-Side Bet On The TL1A Boom

Shattuck Labs pivots to DR3-targeted IBD therapy SL-325, funded through a Phase 2b readout as it competes with anti-TL1A drugs.

Equity Eagle Sep 1

Emerge Commerce ($ECOM.V) FINS Review

Emerge Commerce's $44 million COVID-era acquisitions produced losses and impairments, while modestly improved Q2 liquidity leaves its…

Wolf's Substack Aug 30 6 clicks

NTG Clarity Networks ($NCI.V) FINS Review

NTG Clarity’s $18.6M of Q2 service revenue sat in contract assets, while $4.6M cash burn cut cash to $2.85M and raises liquidity concerns.

Wolf's Substack Aug 28 8 clicks

INMB 2026-08-28

INmune Bio: CORDStrom In The Lead After Signs Of UK Regulatory Alignment

INmune Bio's Ebstrocel targets recessive dystrophic epidermolysis bullosa with UK, EU and US filings planned by early 2027, while XPro adds…

Tejo Strategy Investing Aug 28

Late August 2026 Random Ramblings

Higher rates could compress equity multiples and raise AI data center lease costs, while UWMC and Cogent raise questions about CEO-driven…

Yet Another Value Podcast Aug 27 13 clicks

The Verra Sneerer (NASDAQ:VRRM)

Verra Mobility renewed Hertz tolling management for five years. AutoKinex lets rental customers buy tolling, fuel and protection products…

The Oak Bloke Aug 27 6 clicks

VISL · long

Vislink Technologies INC

Vislink Technologies trades near cash after turning EBITDA-positive through a defense communications pivot under DoD Trusted Investor…

Value Investors Club May 6 1 click

Publications we follow

Every publication on this site, hand-picked.

108 publications

YouTube 4

Blogs 12

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

72 accounts

Nominate an account

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.